• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎进展过程中β-连环蛋白表达和激活的变化可预测疾病复发。

Changes in beta-catenin expression and activation during progression of primary sclerosing cholangitis predict disease recurrence.

机构信息

Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.

Department of Pathology, School of Medicine, University of Pittsburgh, S405A-BST, 200 Lothrop Street, Pittsburgh, PA, 15261, USA.

出版信息

Sci Rep. 2022 Jan 7;12(1):206. doi: 10.1038/s41598-021-04358-6.

DOI:10.1038/s41598-021-04358-6
PMID:34997170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8741932/
Abstract

Primary sclerosing cholangitis (PSC) is a rare, chronic, cholestatic liver disease characterized by progressive inflammation and fibrosis of the bile ducts. We have previously demonstrated the importance of Wnt/β-catenin signaling in mouse models of PSC. In this study, we wished to determine the clinical relevance of β-catenin localization in patient samples. In livers explanted from patients diagnosed with PSC, the majority (12/16; 75%) lacked β-catenin protein expression. Biopsies from patients post-transplant were classified as recurrent or non-recurrent based on pathology reports and then scored for β-catenin activation as a function of immunohistochemical localization. Despite lack of statistical significance, patients with recurrent primary disease (n = 11) had a greater percentage of samples with nuclear, transcriptionally active β-catenin (average 58.8%) than those with no recurrence (n = 10; 40.53%), while non-recurrence is correlated with β-catenin staining at the cell surface (average 52.63% for non-recurrent vs. 27.34% for recurrent), as determined by three different methods of analysis. β-catenin score and years-to-endpoint are both strongly associated with recurrence status (p = 0.017 and p = 0.00063, respectively). Finally, there was significant association between higher β-catenin score and increased alkaline phosphatase, a marker of biliary injury and disease progression. Thus, β-catenin expression and activation changes during the progression of PSC, and its localization may be a useful prognostic tool for predicting recurrence of this disease.

摘要

原发性硬化性胆管炎 (PSC) 是一种罕见的慢性胆汁淤积性肝病,其特征为胆管进行性炎症和纤维化。我们之前已经证明了 Wnt/β-连环蛋白信号通路在 PSC 小鼠模型中的重要性。在这项研究中,我们希望确定β-连环蛋白定位在患者样本中的临床相关性。在从诊断为 PSC 的患者中移植的肝脏中,大多数(12/16;75%)缺乏β-连环蛋白蛋白表达。根据病理报告,将移植后的患者活检分为复发或非复发,并根据免疫组织化学定位对β-连环蛋白激活进行评分。尽管没有统计学意义,但原发性疾病复发的患者(n=11)具有核转录活性β-连环蛋白(平均 58.8%)的样本比例大于无复发的患者(n=10;40.53%),而非复发与β-连环蛋白在细胞表面的染色相关(非复发的平均为 52.63%,复发的为 27.34%),这是通过三种不同的分析方法确定的。β-连环蛋白评分和到达终点的时间都与复发状态密切相关(p=0.017 和 p=0.00063)。最后,β-连环蛋白评分与碱性磷酸酶的升高有显著相关性,碱性磷酸酶是胆汁淤积和疾病进展的标志物。因此,β-连环蛋白的表达和激活在 PSC 的进展过程中发生变化,其定位可能是预测这种疾病复发的有用预后工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/9672b6b82b2f/41598_2021_4358_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/845b999cfbab/41598_2021_4358_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/379ab469e947/41598_2021_4358_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/2338110d6d48/41598_2021_4358_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/948741573c1e/41598_2021_4358_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/8cbde6cbf0b6/41598_2021_4358_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/9672b6b82b2f/41598_2021_4358_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/845b999cfbab/41598_2021_4358_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/379ab469e947/41598_2021_4358_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/2338110d6d48/41598_2021_4358_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/948741573c1e/41598_2021_4358_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/8cbde6cbf0b6/41598_2021_4358_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0214/8741932/9672b6b82b2f/41598_2021_4358_Fig6_HTML.jpg

相似文献

1
Changes in beta-catenin expression and activation during progression of primary sclerosing cholangitis predict disease recurrence.原发性硬化性胆管炎进展过程中β-连环蛋白表达和激活的变化可预测疾病复发。
Sci Rep. 2022 Jan 7;12(1):206. doi: 10.1038/s41598-021-04358-6.
2
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.原发性硬化性胆管炎的原位肝移植:单中心12年经验
Ann Surg. 1997 May;225(5):472-81; discussion 481-3. doi: 10.1097/00000658-199705000-00004.
3
A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis.纤维化非依赖的肝脏转录组特征可识别原发性硬化性胆管炎疾病进展的驱动因素。
Hepatology. 2021 Mar;73(3):1105-1116. doi: 10.1002/hep.31488. Epub 2021 Feb 28.
4
Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.原发性硬化性胆管炎肝移植的复发与排斥。
World J Gastroenterol. 2012 Jan 7;18(1):1-15. doi: 10.3748/wjg.v18.i1.1.
5
Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.在活体肝移植后复发性原发性硬化性胆管炎中,活动性肝炎频繁重叠与疾病的快速进展过程有关。
Hum Pathol. 2011 Sep;42(9):1329-36. doi: 10.1016/j.humpath.2010.01.029. Epub 2011 Feb 21.
6
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.新型血清和胆汁蛋白标志物可预测原发性硬化性胆管炎的疾病严重程度和预后。
J Hepatol. 2017 Jun;66(6):1214-1222. doi: 10.1016/j.jhep.2017.01.019. Epub 2017 Feb 2.
7
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.NGM282,一种 FGF19 类似物,在原发性硬化性胆管炎中的作用:一项多中心、随机、双盲、安慰剂对照的 II 期临床试验。
J Hepatol. 2019 Mar;70(3):483-493. doi: 10.1016/j.jhep.2018.10.035. Epub 2018 Nov 9.
8
Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up.原发性硬化性胆管炎的影像学特征:从诊断到肝移植随访。
Radiographics. 2019 Nov-Dec;39(7):1938-1964. doi: 10.1148/rg.2019180213. Epub 2019 Oct 18.
9
Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis.原发性硬化性胆管炎组织学评分系统的适用性和预后价值。
J Hepatol. 2015 Nov;63(5):1212-9. doi: 10.1016/j.jhep.2015.06.008. Epub 2015 Jun 18.
10
Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.增强型肝纤维化检测可预测原发性硬化性胆管炎的无移植生存率:一项多中心研究。
Liver Int. 2017 Oct;37(10):1554-1561. doi: 10.1111/liv.13402. Epub 2017 Apr 13.

引用本文的文献

1
Clostridium Scindens Protects Against Vancomycin-Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR-FGF15/19 Signaling.梭状芽孢杆菌通过激活肠道FXR-FGF15/19信号通路预防万古霉素诱导的胆汁淤积和肝纤维化。
Adv Sci (Weinh). 2025 Feb;12(5):e2406445. doi: 10.1002/advs.202406445. Epub 2024 Dec 16.
2
Loss of β-catenin reveals a role for glutathione in regulating oxidative stress during cholestatic liver disease.β-连环蛋白的缺失揭示了谷胱甘肽在胆汁淤积性肝病期间调节氧化应激中的作用。
Hepatol Commun. 2024 Jul 5;8(7). doi: 10.1097/HC9.0000000000000485. eCollection 2024 Jul 1.
3
FXR Friend-ChIPs in the Enterohepatic System.

本文引用的文献

1
A novel non-bile acid FXR agonist EDP-305 potently suppresses liver injury and fibrosis without worsening of ductular reaction.一种新型非胆汁酸法尼醇X受体激动剂EDP-305可有效抑制肝损伤和纤维化,且不会加重小胆管反应。
Liver Int. 2020 Jul;40(7):1655-1669. doi: 10.1111/liv.14490. Epub 2020 May 6.
2
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis.一项奥贝胆酸治疗原发性硬化性胆管炎的随机、安慰剂对照、II 期研究。
J Hepatol. 2020 Jul;73(1):94-101. doi: 10.1016/j.jhep.2020.02.033. Epub 2020 Mar 10.
3
Wnt/β-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout Murine Model of Cholestatic Liver Disease.
FXR 朋友在肠肝系统中的 ChIPs。
Semin Liver Dis. 2023 Aug;43(3):267-278. doi: 10.1055/a-2128-5538. Epub 2023 Jul 13.
Wnt/β-连环蛋白信号在胆汁淤积性肝病 Mdr2 敲除小鼠模型中发挥保护作用。
Hepatology. 2020 May;71(5):1732-1749. doi: 10.1002/hep.30927. Epub 2019 Dec 31.
4
Pathological patterns of biliary disease.胆道疾病的病理模式。
Clin Liver Dis (Hoboken). 2017 Nov 30;10(5):107-110. doi: 10.1002/cld.667. eCollection 2017 Nov.
5
Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.原发性胆汁性胆管炎患者奥贝胆酸的长期疗效和安全性:一项国际开放标签扩展研究的 3 年结果。
Lancet Gastroenterol Hepatol. 2019 Jun;4(6):445-453. doi: 10.1016/S2468-1253(19)30094-9. Epub 2019 Mar 26.
6
Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.系统评价与荟萃分析:肝移植后原发性硬化性胆管炎复发的危险因素。
Aliment Pharmacol Ther. 2019 Mar;49(6):636-643. doi: 10.1111/apt.15148. Epub 2019 Feb 10.
7
Primary sclerosing cholangitis.原发性硬化性胆管炎。
Lancet. 2018 Jun 23;391(10139):2547-2559. doi: 10.1016/S0140-6736(18)30300-3. Epub 2018 Feb 13.
8
Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology.Wnt/β-连环蛋白信号在肝脏发育、稳态和病理生物学中的作用。
Annu Rev Pathol. 2018 Jan 24;13:351-378. doi: 10.1146/annurev-pathol-020117-044010. Epub 2017 Nov 10.
9
Primary sclerosing cholangitis - a comprehensive review.原发性硬化性胆管炎——全面综述。
J Hepatol. 2017 Dec;67(6):1298-1323. doi: 10.1016/j.jhep.2017.07.022. Epub 2017 Aug 10.
10
β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.β-连环蛋白调节法尼醇 X 受体信号和胆汁酸代谢在小鼠胆汁淤积。
Hepatology. 2018 Mar;67(3):955-971. doi: 10.1002/hep.29371. Epub 2018 Jan 26.